[TNGX] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
31-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -267.96%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 36,527 24,860 37,042 7,656 24,649 10.32%
PBT -101,610 -108,122 -57,943 -51,972 -14,095 63.80%
Tax 134 54 292 -108 0 -
NP -101,744 -108,176 -58,235 -51,864 -14,095 63.85%
Tax Rate - - - - - -
Total Cost 138,271 133,036 95,277 59,520 38,744 37.41%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -278.54 -435.14 -157.21 -677.43 -57.18 48.52%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.08 -1.23 -0.94 -1.62 -1.57 -8.92%
EPS Diluted -1.08 -1.23 -0.94 -1.62 -1.57 -8.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.